We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App


ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

New Hybrid PET/MRI System Aims to Improve Breast Cancer Diagnosis

By MedImaging International staff writers
Posted on 10 Mar 2022
Print article
Image: Digital hybrid breast PET/MRI for enhanced diagnosis of breast cancer (Photo courtesy of HYPMED)
Image: Digital hybrid breast PET/MRI for enhanced diagnosis of breast cancer (Photo courtesy of HYPMED)

Breast cancer is one of the leading causes of cancer death in women and a major socioeconomic issue throughout the world. With the detection methods available today, diagnosing breast cancer early enough is still not possible in many cases. As well as the problem of detection, there is an ever-increasing need for improved non-invasive characterization of cancer. Targeted therapies require an in-depth analysis of cancer to select and guide appropriate treatment. Both, positron emission tomography (PET) and magnetic resonance imaging (MRI) can provide molecular and functional information that may be of vital importance to tailoring a patient's therapy. However, current whole-body PET/MRI systems lack the necessary sensitivity and resolution for this task. Now, HYPMED, a consortium of 10 partner organizations from Europe that includes major universities, research institutes, clinics as well as major industry and small-to-medium-sized enterprises, is developing a hybrid system of the two medical imaging modalities (MRI and PET) for improved diagnosis of breast cancer and personalized therapy control.

The HYPMED project, coordinated by the European Institute for Biomedical imaging (EIBIR, Vienna, Austria), aims to develop a radiofrequency coil that can be connected to any regular clinical MR scanner and transform the device into a high-resolution PET/MRI hybrid system, which can be used to identify even the smallest breast cancer tumors and better characterize the cancer, as well as its response to therapy. Patients will also benefit as the radiation dose of this new technology will, in contrast to other PET-MRI examinations, be comparable to a regular digital mammogram.

To achieve this, the HYPMED research team will integrate a fully digital MRI-transparent PET detector into a novel multichannel PET transparent MRI surface coil. The PET-RF insert will allow vastly improved imaging of breast cancer with high resolution and ultra-high sensitivity PET, combined with a high level of structural and functional MRI. It will also facilitate minimally invasive MRI and PET-guided targeted biopsy. With HYPMED's PET-RF insert, any regular clinical MRI scan could, upon demand, be turned into a hybrid PET system

The project will also evaluate the impact of this technology on breast cancer diagnosis, prediction, and monitoring/assessment of treatment response through a carefully designed clinical study that employs established and novel PET tracers in 250 patients. Imaging data will be correlated with established and novel molecular biomarkers and the results will be compared to those obtained from whole-body PET/MRI and PET/CT. A multidisciplinary consortium of clinical scientists, three SMEs and an industry partner will pave the way for the commercialization of HYPMED products for advanced clinical decision making in cancer patients. Once HYPMED is successful, the project's partners aim to expand this innovation to other medical applications such as prostate cancer or cardiac hybrid imaging, and introduce a paradigm shift in the field of PET/MR hybrid imaging as a whole.

Related Links:

Print article
Sun Nuclear



view channel
Image: CE-marked and FDA-cleared ExacTrac Dynamic enables the delivery of precision radiotherapy (Photo courtesy of Brainlab)

Next-Gen Technology Enables Precision Radiotherapy with “On-The-Fly” X-Ray Confirmation

Deep Inspiration Breath Hold (DIBH) is a well-established technique and standard of care in treating breast cancer with radiation therapy. When a patient takes a deep breath, the distance between the heart... Read more


view channel
Image: fMRI can be used as non-invasive method for predicting complications in chronic liver disease (Photo courtesy of Pexels)

Functional MRI (fMRI) Offers Non-Invasive Method for Risk Assessment in Liver Disease

In a recent study, a team of scientists has shown that functional magnetic resonance imaging (fMRI) can be used as a non-invasive method for predicting complications in chronic liver disease.... Read more


view channel
Image: Resona I9 ultrasound system features innovative design elements (Photo courtesy of Mindray)

Mindray’s Latest Resona I9 Ultrasound System Provides Innovation-Driven Experience

Mindray (Shenzhen, China) has launched a new ultrasound system which provides an entirely new experience, driven by innovation to address today’s clinical challenges. Mindray’s latest Resona I9 ultrasound... Read more

Imaging IT

view channel

Global AI in Medical Diagnostics Market to Be Driven by Demand for Image Recognition in Radiology

The global artificial intelligence (AI) in medical diagnostics market is expanding with early disease detection being one of its key applications and image recognition becoming a compelling consumer proposition... Read more

Industry News

view channel
Image: Global diagnostic imaging market is driven by technological advancements (Photo courtesy of Pexels)

Global Diagnostic Imaging Market to Surpass USD 33 Billion by 2026

The global diagnostic imaging market is one of the most critical segments of the healthcare sector. Medical imaging helps in early detection and diagnosis of diseases at a stage when they can be easily... Read more
Copyright © 2000-2022 Globetech Media. All rights reserved.